Skip to main content
TipRanks
Go Ultimate75% OFF

Microbix Biosystms (MBX) Financial Statements

39 Followers

Microbix Biosystms Financial Overview

Microbix Biosystms's market cap is currently C$40.41M. The company's EPS TTM is C$-0.04; its P/E ratio is -8.36; Microbix Biosystms has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Sep 25Sep 24Sep 23Sep 22Sep 21
Income Statement
Total RevenueC$ 18.59MC$ 25.39MC$ 16.51MC$ 19.08MC$ 18.59M
Gross ProfitC$ 9.85MC$ 15.39MC$ 7.48MC$ 11.12MC$ 11.04M
Operating IncomeC$ -1.58MC$ 3.91MC$ -2.74MC$ 2.69MC$ 4.84M
EBITDAC$ 428.23KC$ 6.21MC$ 1.96MC$ 3.73MC$ 5.66M
Net IncomeC$ -2.25MC$ 3.52MC$ -39.48KC$ 1.79MC$ 1.63M
Balance Sheet
Cash & Short-Term InvestmentsC$ 12.11MC$ 12.96MC$ 11.61MC$ 13.49MC$ 9.99M
Total AssetsC$ 37.41MC$ 38.10MC$ 35.65MC$ 33.15MC$ 28.83M
Total DebtC$ 6.77MC$ 6.40MC$ 6.65MC$ 5.82MC$ 7.74M
Net DebtC$ -5.34MC$ -6.57MC$ -4.96MC$ -7.66MC$ -2.25M
Total LiabilitiesC$ 9.62MC$ 9.80MC$ 11.03MC$ 8.21MC$ 10.27M
Stockholders' EquityC$ 27.79MC$ 28.30MC$ 24.62MC$ 24.94MC$ 18.56M
Cash Flow
Free Cash FlowC$ -877.58KC$ 2.44MC$ -2.11MC$ 1.44MC$ 804.20K
Operating Cash FlowC$ -80.29KC$ 4.35MC$ -1.09MC$ 3.47MC$ 2.11M
Investing Cash FlowC$ -797.30KC$ -1.91MC$ -1.02MC$ -2.03MC$ -622.34K
Financing Cash FlowC$ 27.00KC$ -1.08MC$ 229.21KC$ 2.06MC$ 8.41M

Currency in CAD

Microbix Biosystms Earnings and Revenue History

-15M015M30M-80 %-40 %0 %40 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Microbix Biosystms Liabilities to Assets

015M30M45M15 %30 %45 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Microbix Biosystms Cash Flow

-5M-2.5M02.5M5M7.5M10M201720182019202020212022202320242025OperatingInvestingFinancing

Microbix Biosystms Forecast EPS vs Actual EPS

000000Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss